Currently, there's only one chemotherapy agent being used to treat pancreatic cancer. Gemzar (gemcitabine) works for some patients, but not others.

The capacity of cancer to outsmart its opponents is legendary. That's why therapies have to be multifaceted. New research shows that going after two targets hits the bulls-eye in knocking the lights out of tumors.

People with chronic myeloid leukemia ( CML ) have been treated with interferon therapy for years, but this treatment can sometimes fail. And when it does, a targeted therapy hits the mark, offering these patients long-term benefits.

Prostate cancer does not always have to be treated. If it's slow growing, active surveillance may be the best course. For older men who have other conditions, prostate cancer probably ought to be left alone.

A study looking at a rare set of tumors that make hormones was given a second look, coming to some new conclusions.

In the United States, more than 600 patient organizations, government agencies, educational institutions, clinical centers, and companies have partnered to participate in the 5th Annual Rare Disease Day February 29, 2012. And on this day, dailyRx is taking a look at rare cancers known as neuroendocrine tumors, or NETs.

People who've had chemotherapy often complain of " chemobrain ," that's characterized by poorer memory and slower thinking. A recently released study has found for some women who had a specific chemotherapy regimen, chemobrain is real and long lasting.

Could this dream come true? A medication that's currently approved for one disease could make Alzheimer's disease nothing more than a nightmarish memory.

If your good night's sleep is only achieved with a prescription, you may want to explore other ways to address your insomnia.

Since 2006, doctors have recommended that girls and young women receive vaccinations against human papillomavirus virus ( HPV ), primarily to prevent cervical cancer. Boys are now being urged to have these vaccines to prevent other forms of cancer.